Shuk-Mei Ho
Concepts (542)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phenols | 29 | 2021 | 113 | 7.920 |
Why?
| Benzhydryl Compounds | 28 | 2021 | 67 | 7.070 |
Why?
| Prostatic Neoplasms | 34 | 2022 | 396 | 5.780 |
Why?
| Prostate | 24 | 2020 | 117 | 4.520 |
Why?
| Epigenesis, Genetic | 19 | 2024 | 373 | 4.180 |
Why?
| Estradiol | 21 | 2021 | 225 | 4.020 |
Why?
| DNA Methylation | 23 | 2020 | 548 | 4.010 |
Why?
| Endocrine Disruptors | 16 | 2024 | 30 | 3.540 |
Why?
| Estrogen Receptor beta | 17 | 2019 | 54 | 3.230 |
Why?
| Prenatal Exposure Delayed Effects | 11 | 2021 | 181 | 2.880 |
Why?
| Gene Expression Regulation, Neoplastic | 19 | 2024 | 829 | 2.290 |
Why?
| Environmental Pollutants | 7 | 2024 | 91 | 1.820 |
Why?
| Estrogens | 13 | 2020 | 227 | 1.810 |
Why?
| Testosterone | 8 | 2016 | 139 | 1.730 |
Why?
| Maternal Exposure | 4 | 2021 | 86 | 1.710 |
Why?
| Air Pollutants, Occupational | 4 | 2020 | 17 | 1.620 |
Why?
| Occupational Exposure | 4 | 2021 | 122 | 1.540 |
Why?
| Spermatogenesis | 2 | 2021 | 9 | 1.370 |
Why?
| Environmental Exposure | 8 | 2024 | 200 | 1.340 |
Why?
| Animals | 54 | 2024 | 13150 | 1.270 |
Why?
| Male | 67 | 2022 | 25093 | 1.260 |
Why?
| Rats | 25 | 2021 | 3300 | 1.240 |
Why?
| Diet, High-Fat | 4 | 2021 | 222 | 1.220 |
Why?
| Breast Neoplasms | 10 | 2016 | 1169 | 1.150 |
Why?
| Asthma | 4 | 2013 | 283 | 1.150 |
Why?
| Gene Expression Profiling | 11 | 2015 | 1031 | 1.100 |
Why?
| CpG Islands | 7 | 2016 | 107 | 1.070 |
Why?
| Pregnancy | 20 | 2023 | 2584 | 1.070 |
Why?
| Receptors, Estrogen | 6 | 2019 | 130 | 1.060 |
Why?
| Cell Line, Tumor | 24 | 2024 | 1402 | 1.050 |
Why?
| Centrosome | 2 | 2016 | 11 | 1.050 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2017 | 122 | 1.030 |
Why?
| Veterans | 2 | 2021 | 550 | 0.990 |
Why?
| Humans | 76 | 2024 | 49827 | 0.950 |
Why?
| Butter | 2 | 2021 | 6 | 0.950 |
Why?
| Air Pollutants | 4 | 2017 | 61 | 0.940 |
Why?
| Adenocarcinoma | 5 | 2015 | 401 | 0.930 |
Why?
| Female | 47 | 2023 | 26329 | 0.920 |
Why?
| Rats, Sprague-Dawley | 15 | 2021 | 1595 | 0.890 |
Why?
| Metallothionein | 2 | 2015 | 9 | 0.890 |
Why?
| Cell Movement | 4 | 2014 | 247 | 0.860 |
Why?
| Response Elements | 2 | 2013 | 29 | 0.830 |
Why?
| Promoter Regions, Genetic | 9 | 2019 | 477 | 0.830 |
Why?
| Infertility, Male | 1 | 2021 | 12 | 0.800 |
Why?
| Estrogens, Non-Steroidal | 8 | 2015 | 16 | 0.800 |
Why?
| Signal Transduction | 14 | 2020 | 1617 | 0.780 |
Why?
| Cell Proliferation | 10 | 2017 | 1007 | 0.770 |
Why?
| Dietary Fats | 1 | 2021 | 133 | 0.750 |
Why?
| Toxicity Tests | 1 | 2020 | 52 | 0.740 |
Why?
| MicroRNAs | 5 | 2016 | 354 | 0.730 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 42 | 0.720 |
Why?
| Racemases and Epimerases | 2 | 2011 | 15 | 0.710 |
Why?
| Disease Susceptibility | 4 | 2012 | 89 | 0.680 |
Why?
| Aging | 4 | 2017 | 688 | 0.670 |
Why?
| Gene Regulatory Networks | 3 | 2017 | 107 | 0.670 |
Why?
| Prostatic Intraepithelial Neoplasia | 4 | 2015 | 8 | 0.660 |
Why?
| Military Personnel | 1 | 2020 | 157 | 0.640 |
Why?
| Stress, Psychological | 1 | 2020 | 260 | 0.640 |
Why?
| Epigenomics | 2 | 2016 | 67 | 0.640 |
Why?
| Anxiety | 1 | 2020 | 269 | 0.640 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2016 | 595 | 0.630 |
Why?
| Benzo(a)pyrene | 3 | 2017 | 12 | 0.630 |
Why?
| Chromosomes, Human, X | 1 | 2018 | 19 | 0.630 |
Why?
| Reproduction | 2 | 2016 | 61 | 0.610 |
Why?
| Depressive Disorder | 1 | 2020 | 339 | 0.610 |
Why?
| Receptors, G-Protein-Coupled | 2 | 2016 | 53 | 0.610 |
Why?
| Embryonic Development | 2 | 2015 | 17 | 0.590 |
Why?
| Genetic Predisposition to Disease | 4 | 2015 | 510 | 0.590 |
Why?
| Pneumonia, Viral | 1 | 2020 | 168 | 0.590 |
Why?
| Microtubules | 2 | 2016 | 41 | 0.590 |
Why?
| Transcription, Genetic | 5 | 2013 | 371 | 0.590 |
Why?
| Coronavirus Infections | 1 | 2020 | 178 | 0.580 |
Why?
| Research Design | 2 | 2019 | 343 | 0.580 |
Why?
| Cell Transformation, Neoplastic | 5 | 2017 | 177 | 0.580 |
Why?
| Rats, Inbred Strains | 6 | 2015 | 196 | 0.570 |
Why?
| Dose-Response Relationship, Drug | 10 | 2020 | 1374 | 0.560 |
Why?
| Vehicle Emissions | 3 | 2017 | 10 | 0.560 |
Why?
| Gene Expression Regulation | 7 | 2018 | 979 | 0.550 |
Why?
| Environmental Health | 1 | 2016 | 12 | 0.540 |
Why?
| Epithelial Cells | 4 | 2015 | 209 | 0.540 |
Why?
| Sexual Maturation | 1 | 2015 | 14 | 0.540 |
Why?
| Prostatic Hyperplasia | 3 | 2015 | 39 | 0.540 |
Why?
| Endoderm | 1 | 2015 | 1 | 0.530 |
Why?
| DNA | 3 | 2016 | 545 | 0.530 |
Why?
| Diethylstilbestrol | 2 | 2008 | 12 | 0.530 |
Why?
| Embryo Implantation | 1 | 2015 | 7 | 0.530 |
Why?
| Transcriptional Activation | 3 | 2013 | 122 | 0.530 |
Why?
| Diabetes, Gestational | 1 | 2016 | 53 | 0.530 |
Why?
| Pandemics | 1 | 2020 | 554 | 0.520 |
Why?
| Mesoderm | 1 | 2015 | 27 | 0.520 |
Why?
| RNA, Untranslated | 1 | 2015 | 14 | 0.520 |
Why?
| Organoids | 1 | 2015 | 39 | 0.520 |
Why?
| Histone Code | 1 | 2015 | 32 | 0.520 |
Why?
| Maternal-Fetal Exchange | 2 | 2020 | 43 | 0.510 |
Why?
| Urinary Bladder Neck Obstruction | 1 | 2015 | 9 | 0.510 |
Why?
| Estrogen Receptor alpha | 6 | 2019 | 89 | 0.510 |
Why?
| Forkhead Transcription Factors | 2 | 2012 | 112 | 0.500 |
Why?
| SEER Program | 1 | 2015 | 98 | 0.490 |
Why?
| Cyclopentanes | 1 | 2014 | 10 | 0.490 |
Why?
| Quinolines | 1 | 2014 | 39 | 0.480 |
Why?
| Endocrinology | 1 | 2014 | 10 | 0.480 |
Why?
| Cadmium | 2 | 2017 | 22 | 0.470 |
Why?
| Ovarian Neoplasms | 2 | 2010 | 448 | 0.460 |
Why?
| Early Detection of Cancer | 1 | 2015 | 165 | 0.450 |
Why?
| Nerve Tissue Proteins | 2 | 2013 | 193 | 0.450 |
Why?
| Calcium-Binding Proteins | 2 | 2011 | 54 | 0.450 |
Why?
| Histone Acetyltransferases | 1 | 2013 | 22 | 0.450 |
Why?
| Toluene 2,4-Diisocyanate | 1 | 2013 | 1 | 0.450 |
Why?
| Cell Differentiation | 2 | 2015 | 653 | 0.440 |
Why?
| Diet | 2 | 2015 | 564 | 0.440 |
Why?
| Androgens | 4 | 2022 | 69 | 0.440 |
Why?
| Cell Division | 1 | 2014 | 292 | 0.440 |
Why?
| Integrin alpha6 | 1 | 2012 | 2 | 0.440 |
Why?
| Transcriptome | 1 | 2015 | 313 | 0.430 |
Why?
| Laminin | 1 | 2012 | 18 | 0.430 |
Why?
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 1 | 0.420 |
Why?
| Dual-Specificity Phosphatases | 1 | 2012 | 2 | 0.420 |
Why?
| RNA, Small Interfering | 6 | 2016 | 215 | 0.420 |
Why?
| Oxidative Stress | 3 | 2007 | 768 | 0.420 |
Why?
| Firefighters | 1 | 2012 | 4 | 0.420 |
Why?
| Receptors, Androgen | 4 | 2022 | 46 | 0.420 |
Why?
| Interferon-gamma | 1 | 2013 | 174 | 0.410 |
Why?
| Gene-Environment Interaction | 1 | 2012 | 36 | 0.410 |
Why?
| HMGN Proteins | 1 | 2011 | 1 | 0.410 |
Why?
| Colorectal Neoplasms | 1 | 2015 | 234 | 0.410 |
Why?
| Occupational Diseases | 1 | 2013 | 89 | 0.410 |
Why?
| Mass Screening | 1 | 2015 | 351 | 0.400 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 488 | 0.400 |
Why?
| Endocrine Glands | 1 | 2011 | 5 | 0.380 |
Why?
| Endocrine System Diseases | 1 | 2011 | 10 | 0.380 |
Why?
| Risk | 4 | 2017 | 320 | 0.380 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 20 | 0.380 |
Why?
| Gene Silencing | 2 | 2010 | 121 | 0.370 |
Why?
| RNA | 2 | 2012 | 170 | 0.370 |
Why?
| Prolactin | 1 | 2010 | 44 | 0.370 |
Why?
| RNA, Messenger | 8 | 2022 | 1105 | 0.370 |
Why?
| Liver Neoplasms | 3 | 2024 | 332 | 0.370 |
Why?
| Membrane Proteins | 2 | 2010 | 342 | 0.360 |
Why?
| Introns | 1 | 2010 | 49 | 0.360 |
Why?
| Immunohistochemistry | 8 | 2016 | 971 | 0.360 |
Why?
| Genetic Vectors | 1 | 2010 | 127 | 0.360 |
Why?
| Sex Characteristics | 3 | 2018 | 190 | 0.360 |
Why?
| Proteins | 3 | 2008 | 341 | 0.340 |
Why?
| Coenzyme A Ligases | 1 | 2009 | 4 | 0.340 |
Why?
| Anticarcinogenic Agents | 2 | 2006 | 34 | 0.340 |
Why?
| Disease Models, Animal | 7 | 2024 | 1451 | 0.330 |
Why?
| Mice | 14 | 2024 | 5720 | 0.330 |
Why?
| Histones | 5 | 2016 | 315 | 0.330 |
Why?
| Risk Factors | 5 | 2020 | 3619 | 0.320 |
Why?
| Orphan Nuclear Receptors | 2 | 2019 | 15 | 0.320 |
Why?
| Antigens, Neoplasm | 1 | 2009 | 151 | 0.310 |
Why?
| Deoxyguanosine | 2 | 2007 | 27 | 0.300 |
Why?
| Organ Culture Techniques | 1 | 2007 | 50 | 0.300 |
Why?
| Polymerase Chain Reaction | 1 | 2009 | 455 | 0.300 |
Why?
| Cells, Cultured | 7 | 2019 | 1571 | 0.300 |
Why?
| Fetus | 1 | 2009 | 217 | 0.300 |
Why?
| Ethinyl Estradiol | 2 | 2018 | 8 | 0.300 |
Why?
| Adult | 11 | 2020 | 13160 | 0.290 |
Why?
| Age Factors | 4 | 2015 | 1090 | 0.290 |
Why?
| Apigenin | 1 | 2006 | 5 | 0.290 |
Why?
| Estrogen Receptor Modulators | 1 | 2006 | 5 | 0.290 |
Why?
| Molecular Biology | 1 | 2007 | 25 | 0.290 |
Why?
| Cell Line | 4 | 2016 | 1002 | 0.280 |
Why?
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2006 | 6 | 0.280 |
Why?
| Protein Isoforms | 4 | 2013 | 119 | 0.280 |
Why?
| Carcinoma, Hepatocellular | 2 | 2024 | 194 | 0.280 |
Why?
| Epithelium | 3 | 2014 | 65 | 0.270 |
Why?
| Molecular Sequence Data | 5 | 2012 | 797 | 0.270 |
Why?
| Antineoplastic Agents, Hormonal | 3 | 2014 | 47 | 0.270 |
Why?
| Cytochrome P-450 CYP1A1 | 1 | 2005 | 26 | 0.260 |
Why?
| Proteomics | 1 | 2008 | 328 | 0.250 |
Why?
| Middle Aged | 11 | 2020 | 11997 | 0.250 |
Why?
| Carcinogens | 3 | 2015 | 199 | 0.250 |
Why?
| Animals, Newborn | 5 | 2018 | 366 | 0.240 |
Why?
| NF-kappa B | 1 | 2006 | 314 | 0.240 |
Why?
| Estrogen Antagonists | 2 | 2012 | 21 | 0.240 |
Why?
| DNA-Binding Proteins | 3 | 2016 | 436 | 0.230 |
Why?
| Antioxidants | 1 | 2006 | 248 | 0.230 |
Why?
| Mice, Knockout | 2 | 2024 | 841 | 0.230 |
Why?
| Base Sequence | 4 | 2012 | 650 | 0.230 |
Why?
| beta Catenin | 1 | 2024 | 102 | 0.230 |
Why?
| Wnt Signaling Pathway | 1 | 2024 | 92 | 0.220 |
Why?
| Stem Cells | 2 | 2015 | 171 | 0.220 |
Why?
| Interferons | 2 | 2015 | 40 | 0.220 |
Why?
| Kidney | 1 | 2007 | 665 | 0.220 |
Why?
| Tumor Suppressor Proteins | 2 | 2020 | 127 | 0.210 |
Why?
| Immediate-Early Proteins | 1 | 2002 | 19 | 0.210 |
Why?
| Reproducibility of Results | 5 | 2020 | 1188 | 0.210 |
Why?
| Pregnancy Outcome | 2 | 2017 | 237 | 0.210 |
Why?
| Arabidopsis Proteins | 1 | 2002 | 23 | 0.200 |
Why?
| Inheritance Patterns | 1 | 2021 | 22 | 0.200 |
Why?
| Gene Expression | 3 | 2011 | 608 | 0.200 |
Why?
| Incineration | 1 | 2021 | 5 | 0.200 |
Why?
| Testis | 1 | 2021 | 69 | 0.190 |
Why?
| HEK293 Cells | 4 | 2016 | 222 | 0.190 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2021 | 56 | 0.190 |
Why?
| Loneliness | 1 | 2020 | 11 | 0.190 |
Why?
| Hypesthesia | 1 | 2020 | 17 | 0.190 |
Why?
| Mammary Glands, Animal | 2 | 2020 | 69 | 0.190 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2008 | 412 | 0.180 |
Why?
| Chromatin Immunoprecipitation | 3 | 2016 | 49 | 0.180 |
Why?
| Tissue Array Analysis | 4 | 2016 | 45 | 0.180 |
Why?
| DNA Modification Methylases | 1 | 2020 | 28 | 0.180 |
Why?
| Isocitrate Dehydrogenase | 1 | 2020 | 17 | 0.180 |
Why?
| Memory Disorders | 1 | 2020 | 54 | 0.180 |
Why?
| DNA Repair Enzymes | 1 | 2020 | 43 | 0.180 |
Why?
| Pyruvate Kinase | 1 | 2020 | 7 | 0.180 |
Why?
| Phenotype | 2 | 2015 | 727 | 0.180 |
Why?
| Fear | 1 | 2020 | 81 | 0.180 |
Why?
| Random Allocation | 2 | 2017 | 280 | 0.170 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 91 | 0.170 |
Why?
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 181 | 0.170 |
Why?
| Methylation | 2 | 2020 | 123 | 0.170 |
Why?
| Neoplasm Metastasis | 2 | 2014 | 231 | 0.170 |
Why?
| Image Processing, Computer-Assisted | 2 | 2016 | 241 | 0.170 |
Why?
| Glioma | 1 | 2020 | 79 | 0.170 |
Why?
| Mice, Transgenic | 2 | 2015 | 555 | 0.170 |
Why?
| Endometrial Neoplasms | 1 | 2020 | 137 | 0.170 |
Why?
| Blotting, Western | 3 | 2016 | 602 | 0.170 |
Why?
| Urethra | 2 | 2020 | 88 | 0.170 |
Why?
| Collagen Type III | 1 | 2019 | 7 | 0.170 |
Why?
| Subcellular Fractions | 2 | 2012 | 34 | 0.170 |
Why?
| Gonadal Steroid Hormones | 2 | 2011 | 42 | 0.170 |
Why?
| Adaptation, Psychological | 1 | 2020 | 223 | 0.170 |
Why?
| Protein Binding | 3 | 2011 | 660 | 0.160 |
Why?
| Liver Failure, Acute | 1 | 2019 | 53 | 0.160 |
Why?
| Models, Genetic | 2 | 2011 | 174 | 0.160 |
Why?
| Methylmercury Compounds | 1 | 2018 | 6 | 0.160 |
Why?
| Denmark | 1 | 2018 | 44 | 0.160 |
Why?
| Collagen Type I | 1 | 2019 | 89 | 0.160 |
Why?
| Linear Models | 1 | 2019 | 281 | 0.160 |
Why?
| Cohort Studies | 2 | 2014 | 1422 | 0.160 |
Why?
| DNA Primers | 2 | 2011 | 206 | 0.160 |
Why?
| Polychlorinated Biphenyls | 1 | 2018 | 25 | 0.160 |
Why?
| Hair | 1 | 2018 | 30 | 0.160 |
Why?
| Computational Biology | 2 | 2017 | 214 | 0.150 |
Why?
| Electronic Waste | 1 | 2017 | 1 | 0.150 |
Why?
| Fetal Blood | 1 | 2018 | 67 | 0.150 |
Why?
| Lysine | 2 | 2015 | 90 | 0.150 |
Why?
| Water Pollutants, Chemical | 1 | 2018 | 41 | 0.150 |
Why?
| Histone Demethylases | 1 | 2017 | 16 | 0.150 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 25 | 0.150 |
Why?
| T-Lymphocytes | 2 | 2017 | 338 | 0.150 |
Why?
| Urethane | 1 | 2017 | 6 | 0.150 |
Why?
| Survival Analysis | 2 | 2016 | 659 | 0.150 |
Why?
| Neoplasm Staging | 2 | 2014 | 746 | 0.150 |
Why?
| Infant, Newborn | 3 | 2023 | 2744 | 0.150 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2019 | 202 | 0.150 |
Why?
| Antigens, CD1 | 1 | 2017 | 9 | 0.150 |
Why?
| Antigen Presentation | 1 | 2017 | 25 | 0.150 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2008 | 9 | 0.150 |
Why?
| Genomic Imprinting | 2 | 2008 | 11 | 0.150 |
Why?
| Models, Biological | 4 | 2017 | 728 | 0.150 |
Why?
| Aged | 8 | 2020 | 9272 | 0.150 |
Why?
| Tumor Cells, Cultured | 2 | 2014 | 465 | 0.140 |
Why?
| Fibroblasts | 1 | 2019 | 343 | 0.140 |
Why?
| Acetylation | 2 | 2015 | 99 | 0.140 |
Why?
| Cholesterol | 1 | 2017 | 146 | 0.140 |
Why?
| Brain Neoplasms | 1 | 2020 | 286 | 0.140 |
Why?
| 5-Methylcytosine | 1 | 2016 | 16 | 0.140 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2014 | 210 | 0.140 |
Why?
| Exercise | 1 | 2020 | 490 | 0.140 |
Why?
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 14 | 0.140 |
Why?
| Methyltransferases | 1 | 2016 | 28 | 0.140 |
Why?
| Hippocampus | 1 | 2018 | 228 | 0.140 |
Why?
| Heart Diseases | 1 | 2019 | 208 | 0.140 |
Why?
| Genetic Loci | 1 | 2016 | 49 | 0.140 |
Why?
| Myocardium | 1 | 2019 | 429 | 0.130 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 56 | 0.130 |
Why?
| Hepatocyte Nuclear Factor 4 | 1 | 2015 | 3 | 0.130 |
Why?
| Genital Neoplasms, Male | 1 | 2015 | 2 | 0.130 |
Why?
| Exosomes | 1 | 2016 | 42 | 0.130 |
Why?
| Prognosis | 3 | 2017 | 1952 | 0.130 |
Why?
| Immunologic Surveillance | 1 | 2015 | 10 | 0.130 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2015 | 51 | 0.130 |
Why?
| Incidence | 2 | 2017 | 1003 | 0.130 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2016 | 105 | 0.130 |
Why?
| Environment | 1 | 2016 | 85 | 0.130 |
Why?
| Cell Survival | 2 | 2008 | 598 | 0.130 |
Why?
| Myeloid Cells | 1 | 2015 | 39 | 0.130 |
Why?
| Prostatectomy | 1 | 2016 | 82 | 0.130 |
Why?
| Isoenzymes | 2 | 2006 | 168 | 0.130 |
Why?
| Mammaglobin B | 1 | 2015 | 1 | 0.130 |
Why?
| Genital Neoplasms, Female | 1 | 2015 | 41 | 0.130 |
Why?
| Lung Neoplasms | 2 | 2020 | 605 | 0.130 |
Why?
| Placenta | 1 | 2016 | 132 | 0.130 |
Why?
| Age Distribution | 1 | 2015 | 170 | 0.120 |
Why?
| Cluster Analysis | 1 | 2015 | 235 | 0.120 |
Why?
| Urinary Bladder | 1 | 2015 | 92 | 0.120 |
Why?
| Hyperplasia | 1 | 2015 | 99 | 0.120 |
Why?
| Inflammasomes | 1 | 2015 | 58 | 0.120 |
Why?
| Precancerous Conditions | 2 | 2006 | 83 | 0.120 |
Why?
| Schools | 1 | 2016 | 165 | 0.120 |
Why?
| Up-Regulation | 4 | 2019 | 450 | 0.120 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2014 | 47 | 0.120 |
Why?
| Gestational Age | 1 | 2016 | 417 | 0.120 |
Why?
| Immunoenzyme Techniques | 1 | 2014 | 143 | 0.120 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2014 | 21 | 0.120 |
Why?
| History, 21st Century | 1 | 2014 | 57 | 0.120 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 126 | 0.120 |
Why?
| History, 20th Century | 1 | 2014 | 100 | 0.120 |
Why?
| Protein Processing, Post-Translational | 2 | 2012 | 171 | 0.120 |
Why?
| Age of Onset | 1 | 2014 | 106 | 0.120 |
Why?
| Gene Deletion | 1 | 2015 | 266 | 0.120 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 469 | 0.120 |
Why?
| Neoplasm Proteins | 1 | 2016 | 323 | 0.110 |
Why?
| Repressor Proteins | 1 | 2014 | 151 | 0.110 |
Why?
| Tamoxifen | 2 | 2012 | 60 | 0.110 |
Why?
| Methacholine Chloride | 1 | 2013 | 3 | 0.110 |
Why?
| Sp1 Transcription Factor | 2 | 2024 | 21 | 0.110 |
Why?
| Exons | 1 | 2013 | 95 | 0.110 |
Why?
| MAP Kinase Kinase Kinase 1 | 1 | 2012 | 4 | 0.110 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 129 | 0.110 |
Why?
| Oncogene Proteins | 1 | 2012 | 17 | 0.110 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2012 | 66 | 0.110 |
Why?
| Saliva | 1 | 2012 | 54 | 0.110 |
Why?
| Young Adult | 4 | 2020 | 3936 | 0.110 |
Why?
| Ovary | 2 | 2020 | 104 | 0.110 |
Why?
| Eyelids | 1 | 2012 | 29 | 0.110 |
Why?
| Smoke | 1 | 2012 | 18 | 0.110 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 40 | 0.100 |
Why?
| In Situ Hybridization | 2 | 2010 | 65 | 0.100 |
Why?
| Child, Preschool | 2 | 2012 | 3853 | 0.100 |
Why?
| Cell Adhesion | 1 | 2012 | 158 | 0.100 |
Why?
| Mice, Nude | 4 | 2014 | 252 | 0.100 |
Why?
| RNA Splicing | 1 | 2012 | 37 | 0.100 |
Why?
| Flow Cytometry | 2 | 2014 | 470 | 0.100 |
Why?
| Azacitidine | 1 | 2011 | 34 | 0.100 |
Why?
| Antibodies | 2 | 2012 | 155 | 0.100 |
Why?
| Phytoestrogens | 2 | 2014 | 22 | 0.100 |
Why?
| Phosphorylation | 3 | 2020 | 536 | 0.100 |
Why?
| Carrier Proteins | 1 | 2013 | 304 | 0.100 |
Why?
| Adult Stem Cells | 1 | 2011 | 10 | 0.100 |
Why?
| Peptide Hormones | 1 | 2011 | 3 | 0.100 |
Why?
| Biomedical Research | 1 | 2014 | 231 | 0.100 |
Why?
| Cell Cycle | 2 | 2012 | 232 | 0.100 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2011 | 36 | 0.100 |
Why?
| Thyroid Hormones | 1 | 2011 | 18 | 0.100 |
Why?
| Calcitriol | 1 | 2011 | 36 | 0.090 |
Why?
| Muscle Proteins | 1 | 2013 | 303 | 0.090 |
Why?
| Tubulin Modulators | 1 | 2011 | 31 | 0.090 |
Why?
| Calgranulin B | 1 | 2010 | 4 | 0.090 |
Why?
| Bromocriptine | 1 | 2010 | 4 | 0.090 |
Why?
| Chemokine CXCL13 | 1 | 2010 | 5 | 0.090 |
Why?
| Nitric Oxide | 1 | 2012 | 253 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 854 | 0.090 |
Why?
| Tretinoin | 1 | 2011 | 53 | 0.090 |
Why?
| Cell Nucleus | 2 | 2016 | 184 | 0.090 |
Why?
| Paclitaxel | 1 | 2011 | 84 | 0.090 |
Why?
| Microscopy, Confocal | 1 | 2010 | 87 | 0.090 |
Why?
| Feedback, Physiological | 1 | 2010 | 12 | 0.090 |
Why?
| Genes, abl | 1 | 2010 | 2 | 0.090 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 73 | 0.090 |
Why?
| Autoimmunity | 1 | 2010 | 35 | 0.090 |
Why?
| Staining and Labeling | 2 | 2016 | 97 | 0.090 |
Why?
| Interleukin-1beta | 1 | 2010 | 75 | 0.090 |
Why?
| Molecular Targeted Therapy | 1 | 2011 | 119 | 0.090 |
Why?
| Microscopy, Fluorescence | 1 | 2010 | 162 | 0.090 |
Why?
| Mice, Inbred C57BL | 4 | 2019 | 1806 | 0.090 |
Why?
| Binding Sites | 2 | 2022 | 377 | 0.080 |
Why?
| Disease-Free Survival | 1 | 2010 | 457 | 0.080 |
Why?
| New York City | 1 | 2009 | 26 | 0.080 |
Why?
| Follow-Up Studies | 1 | 2014 | 2179 | 0.080 |
Why?
| Proportional Hazards Models | 1 | 2010 | 406 | 0.080 |
Why?
| Ecotoxicology | 1 | 2008 | 4 | 0.080 |
Why?
| Administration, Oral | 2 | 2010 | 423 | 0.080 |
Why?
| Genital Diseases, Female | 1 | 2008 | 17 | 0.080 |
Why?
| Clinical Laboratory Techniques | 1 | 2008 | 30 | 0.080 |
Why?
| Child | 2 | 2012 | 6824 | 0.080 |
Why?
| Public Health Practice | 1 | 2008 | 41 | 0.080 |
Why?
| ROC Curve | 1 | 2009 | 232 | 0.080 |
Why?
| Behavior, Animal | 2 | 2020 | 182 | 0.080 |
Why?
| Apoptosis | 1 | 2013 | 1100 | 0.080 |
Why?
| United States | 3 | 2015 | 4838 | 0.080 |
Why?
| Drug Resistance, Neoplasm | 1 | 2010 | 308 | 0.080 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 2007 | 12 | 0.080 |
Why?
| Microdissection | 1 | 2007 | 19 | 0.080 |
Why?
| Cyclooxygenase 2 | 1 | 2007 | 45 | 0.070 |
Why?
| Nitric Oxide Synthase | 1 | 2007 | 75 | 0.070 |
Why?
| Lasers | 1 | 2007 | 119 | 0.070 |
Why?
| Presenilin-2 | 1 | 2006 | 3 | 0.070 |
Why?
| Yeasts | 1 | 2006 | 11 | 0.070 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 19 | 0.070 |
Why?
| Dimerization | 1 | 2006 | 53 | 0.070 |
Why?
| Consensus | 1 | 2007 | 143 | 0.070 |
Why?
| Caspase 3 | 1 | 2006 | 97 | 0.070 |
Why?
| Proteome | 1 | 2008 | 173 | 0.070 |
Why?
| Retrospective Studies | 2 | 2016 | 6117 | 0.070 |
Why?
| Growth Differentiation Factor 1 | 1 | 2006 | 2 | 0.070 |
Why?
| Oxidation-Reduction | 1 | 2007 | 319 | 0.070 |
Why?
| Protein Biosynthesis | 2 | 2013 | 253 | 0.070 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2008 | 388 | 0.070 |
Why?
| Enzyme Activation | 1 | 2006 | 276 | 0.070 |
Why?
| Interleukin-12 | 1 | 2006 | 31 | 0.070 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 51 | 0.070 |
Why?
| Spinacia oleracea | 1 | 2006 | 8 | 0.070 |
Why?
| Interleukin-8 | 1 | 2006 | 87 | 0.070 |
Why?
| Phytotherapy | 1 | 2006 | 44 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 104 | 0.070 |
Why?
| Risk Assessment | 4 | 2015 | 1262 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2013 | 1172 | 0.060 |
Why?
| Models, Molecular | 1 | 2006 | 337 | 0.060 |
Why?
| Amino Acid Sequence | 1 | 2006 | 587 | 0.060 |
Why?
| MCF-7 Cells | 2 | 2016 | 68 | 0.060 |
Why?
| Alternative Splicing | 1 | 2005 | 57 | 0.060 |
Why?
| Oxygen Consumption | 1 | 2006 | 180 | 0.060 |
Why?
| TATA Box | 1 | 2004 | 9 | 0.060 |
Why?
| Dinucleoside Phosphates | 1 | 2004 | 6 | 0.060 |
Why?
| Adolescent | 1 | 2016 | 6340 | 0.060 |
Why?
| Transfection | 1 | 2005 | 357 | 0.060 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2017 | 349 | 0.060 |
Why?
| Infant | 1 | 2012 | 3551 | 0.060 |
Why?
| Tandem Mass Spectrometry | 2 | 2017 | 236 | 0.060 |
Why?
| Orchiectomy | 1 | 2003 | 41 | 0.060 |
Why?
| Oxidoreductases | 1 | 2003 | 57 | 0.060 |
Why?
| Androgen-Binding Protein | 1 | 2003 | 1 | 0.060 |
Why?
| Prostatic Secretory Proteins | 1 | 2003 | 1 | 0.060 |
Why?
| Seminal Vesicle Secretory Proteins | 1 | 2003 | 1 | 0.060 |
Why?
| Peptide Elongation Factor 1 | 1 | 2003 | 2 | 0.060 |
Why?
| Plant Extracts | 1 | 2006 | 190 | 0.060 |
Why?
| Aldehydes | 1 | 2003 | 83 | 0.060 |
Why?
| Clusterin | 1 | 2003 | 6 | 0.060 |
Why?
| Glucosephosphate Dehydrogenase | 1 | 2003 | 6 | 0.060 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2003 | 6 | 0.060 |
Why?
| Glutathione Reductase | 1 | 2003 | 14 | 0.060 |
Why?
| Glutathione Peroxidase | 1 | 2003 | 23 | 0.060 |
Why?
| Postoperative Period | 1 | 2003 | 172 | 0.060 |
Why?
| Malondialdehyde | 1 | 2003 | 51 | 0.060 |
Why?
| Cytoskeleton | 1 | 2003 | 39 | 0.060 |
Why?
| Regeneration | 1 | 2003 | 72 | 0.050 |
Why?
| Catalase | 1 | 2003 | 67 | 0.050 |
Why?
| Metabolome | 1 | 2023 | 88 | 0.050 |
Why?
| Lipid Peroxidation | 1 | 2003 | 100 | 0.050 |
Why?
| Molecular Chaperones | 1 | 2003 | 64 | 0.050 |
Why?
| Alkaline Phosphatase | 1 | 2003 | 94 | 0.050 |
Why?
| Superoxide Dismutase | 1 | 2003 | 113 | 0.050 |
Why?
| Metabolomics | 1 | 2023 | 124 | 0.050 |
Why?
| Glycoproteins | 1 | 2003 | 115 | 0.050 |
Why?
| Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2002 | 1 | 0.050 |
Why?
| Receptors, Vasoactive Intestinal Peptide | 1 | 2002 | 3 | 0.050 |
Why?
| Radioimmunoassay | 1 | 2002 | 44 | 0.050 |
Why?
| Peer Review | 1 | 2002 | 9 | 0.050 |
Why?
| Endocrine System | 1 | 2002 | 16 | 0.050 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 268 | 0.050 |
Why?
| Early Growth Response Protein 1 | 1 | 2002 | 35 | 0.050 |
Why?
| Sp3 Transcription Factor | 1 | 2022 | 5 | 0.050 |
Why?
| RNA Polymerase II | 1 | 2022 | 12 | 0.050 |
Why?
| STAT3 Transcription Factor | 1 | 2002 | 81 | 0.050 |
Why?
| Adenosine Triphosphatases | 1 | 2002 | 87 | 0.050 |
Why?
| Plant Proteins | 1 | 2002 | 70 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 240 | 0.050 |
Why?
| Mutation | 1 | 2007 | 1293 | 0.050 |
Why?
| Mitochondria | 1 | 2005 | 397 | 0.050 |
Why?
| Amino Acids | 1 | 2023 | 358 | 0.050 |
Why?
| Trans-Activators | 1 | 2002 | 134 | 0.050 |
Why?
| Reactive Oxygen Species | 1 | 2003 | 408 | 0.050 |
Why?
| Alcohol Oxidoreductases | 1 | 2020 | 13 | 0.050 |
Why?
| Lymphangioleiomyomatosis | 1 | 2020 | 4 | 0.050 |
Why?
| Thyroid Gland | 1 | 2020 | 73 | 0.040 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2020 | 138 | 0.040 |
Why?
| Hep G2 Cells | 1 | 2019 | 36 | 0.040 |
Why?
| Acetylcysteine | 1 | 2019 | 100 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2023 | 1541 | 0.040 |
Why?
| Transcription Factors | 1 | 2002 | 563 | 0.040 |
Why?
| Rats, Wistar | 1 | 2019 | 223 | 0.040 |
Why?
| Fibrosis | 1 | 2019 | 178 | 0.040 |
Why?
| Biopsy | 1 | 2020 | 582 | 0.040 |
Why?
| Apgar Score | 1 | 2017 | 35 | 0.040 |
Why?
| Pilot Projects | 1 | 2020 | 699 | 0.040 |
Why?
| Heart | 1 | 2020 | 326 | 0.040 |
Why?
| United States Environmental Protection Agency | 2 | 2007 | 8 | 0.040 |
Why?
| Diet, Atherogenic | 1 | 2017 | 8 | 0.040 |
Why?
| China | 1 | 2017 | 87 | 0.040 |
Why?
| Gasoline | 1 | 2017 | 2 | 0.040 |
Why?
| Injections, Intraperitoneal | 1 | 2017 | 54 | 0.040 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 39 | 0.040 |
Why?
| Endosomes | 1 | 2017 | 30 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 2 | 2007 | 46 | 0.040 |
Why?
| Birth Weight | 1 | 2017 | 120 | 0.040 |
Why?
| Endocytosis | 1 | 2017 | 57 | 0.040 |
Why?
| Time Factors | 2 | 2014 | 2912 | 0.040 |
Why?
| Sex Factors | 1 | 2019 | 693 | 0.030 |
Why?
| Lung | 1 | 2020 | 480 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 169 | 0.030 |
Why?
| Acetaminophen | 1 | 2019 | 282 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2017 | 175 | 0.030 |
Why?
| Hormone Replacement Therapy | 1 | 2015 | 27 | 0.030 |
Why?
| Sequence Analysis, DNA | 1 | 2016 | 237 | 0.030 |
Why?
| Drug Implants | 1 | 2015 | 35 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2015 | 123 | 0.030 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 141 | 0.030 |
Why?
| Models, Theoretical | 1 | 2016 | 174 | 0.030 |
Why?
| Organ Size | 1 | 2015 | 226 | 0.030 |
Why?
| Sp Transcription Factors | 1 | 2014 | 6 | 0.030 |
Why?
| Lymphocyte Activation | 1 | 2015 | 172 | 0.030 |
Why?
| Pentacyclic Triterpenes | 1 | 2014 | 8 | 0.030 |
Why?
| Triterpenes | 1 | 2014 | 11 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2015 | 70 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 85 | 0.030 |
Why?
| Transplantation, Heterologous | 1 | 2014 | 74 | 0.030 |
Why?
| HMGA Proteins | 1 | 2014 | 2 | 0.030 |
Why?
| Immunity, Innate | 1 | 2015 | 104 | 0.030 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 69 | 0.030 |
Why?
| Caspase 7 | 1 | 2013 | 6 | 0.030 |
Why?
| Genome | 1 | 2014 | 67 | 0.030 |
Why?
| 5' Untranslated Regions | 1 | 2013 | 31 | 0.030 |
Why?
| Open Reading Frames | 1 | 2013 | 54 | 0.030 |
Why?
| Life Style | 1 | 2014 | 140 | 0.030 |
Why?
| Transcription Factor AP-2 | 1 | 2012 | 3 | 0.030 |
Why?
| Laser Capture Microdissection | 1 | 2012 | 6 | 0.030 |
Why?
| Receptors, Steroid | 1 | 2012 | 19 | 0.030 |
Why?
| Progesterone | 1 | 2012 | 57 | 0.030 |
Why?
| DNA, Complementary | 1 | 2012 | 135 | 0.030 |
Why?
| Tissue Distribution | 1 | 2012 | 164 | 0.030 |
Why?
| Serum Response Factor | 1 | 2012 | 42 | 0.030 |
Why?
| Doxorubicin | 1 | 2013 | 230 | 0.030 |
Why?
| Cell Death | 1 | 2012 | 181 | 0.030 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 83 | 0.020 |
Why?
| Neoplasm Recurrence, Local | 1 | 2016 | 618 | 0.020 |
Why?
| Cisplatin | 1 | 2013 | 278 | 0.020 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 96 | 0.020 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 118 | 0.020 |
Why?
| Genotype | 1 | 2012 | 538 | 0.020 |
Why?
| Albumins | 1 | 2011 | 32 | 0.020 |
Why?
| Inhibitory Concentration 50 | 1 | 2011 | 76 | 0.020 |
Why?
| Microarray Analysis | 1 | 2011 | 73 | 0.020 |
Why?
| Injections, Subcutaneous | 1 | 2010 | 52 | 0.020 |
Why?
| STAT1 Transcription Factor | 1 | 2010 | 26 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2011 | 303 | 0.020 |
Why?
| Carcinoma, Lobular | 1 | 2010 | 33 | 0.020 |
Why?
| Receptors, Progesterone | 1 | 2010 | 63 | 0.020 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2010 | 42 | 0.020 |
Why?
| Drug Delivery Systems | 1 | 2011 | 136 | 0.020 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2010 | 89 | 0.020 |
Why?
| Nanoparticles | 1 | 2011 | 145 | 0.020 |
Why?
| Dihydrotestosterone | 1 | 2007 | 12 | 0.020 |
Why?
| Animals, Wild | 1 | 2007 | 8 | 0.020 |
Why?
| North Carolina | 1 | 2007 | 52 | 0.020 |
Why?
| Models, Animal | 1 | 2007 | 233 | 0.020 |
Why?
| Down-Regulation | 1 | 2007 | 349 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2010 | 3125 | 0.010 |
Why?
| Public Health | 1 | 2002 | 200 | 0.010 |
Why?
|
|
Ho's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|